-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation